Recent developments in transplantation medicine improved the short- and long-term survival of solid-organ transplantation. However, chronic allograft rejection, the side effects of the long-term immunosuppressive treatment, and organ shortage are still the major obstacles to achieving long-term survival. Gene therapy has the potential to meet these challenges and has unique advantages in transplantation. In this review we summarize the studies using gene therapy in solid-organ transplantation.
|Original language||English (US)|
|Issue number||SUPPL. 1|
|State||Published - Jan 1 2002|
- Gene therapy
ASJC Scopus subject areas